Safety and Tolerability Study With Single Ascending Doses of ODM-102

Clinical trial NCT01839019 · COMPLETED

Trial details

NCT number: NCT01839019
Sponsor: Orion Corporation, Orion Pharma
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Volunteers

Start date: 2013-04-01
Primary completion: 2013-06-01
Enrollment: 22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.